G1 Therapeutics, Inc. Profile Avatar - Palmy Investing

G1 Therapeutics, Inc.

G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease c…

Biotechnology
US, Research Triangle Park [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of GTHX's Analysis
CIK: 1560241 CUSIP: 3621LQ109 ISIN: US3621LQ1099 LEI: - UEI: -
Secondary Listings
GTHX has no secondary listings inside our databases.